Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer. (Q45984181)
Jump to navigation
Jump to search
scientific article published on 2 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer. |
scientific article published on 2 June 2009 |
Statements
1 reference
Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer. (English)
1 reference
Kishan J Pandya
1 reference
Ajeet Gajra
1 reference
Ghulam M Warsi
1 reference
Eliza Argonza-Aviles
1 reference
Solveig G Ericson
1 reference
Antoinette J Wozniak
1 reference
2 June 2009
1 reference
1 reference
67
1 reference
3
1 reference
330-338
1 reference